PHO80-PHO85サイクリン-CDK複合体によるPHO4核局所化の制御
E M O'Neill1, A Kaffman, E R Jolly
1Department of Biochemistry and Biophysics, University of California at San Francisco, School of Medicine 94143-0448, USA.
Science (New York, N.Y.)
|January 12, 1996
まとめ
PHO80-PHO85サイクリン-CDK複合体によるPHO4転写因子のリン酸化はPHO5遺伝子発現を調節する. このプロセスはPHO4を制御します.
科学分野:
- 分子生物学は分子生物学である.
- イースト遺伝学 イースト遺伝学
- 遺伝子規制 遺伝子規制
背景:
- イーストのPHO5遺伝子は,リン酸飢餓中に誘発されます.
- PHO4は,PHO5遺伝子の活性化に不可欠な転写因子です.
- サイクリン依存キナーゼであるPHO80-PHO85複合体は,遺伝子発現の調節に関与しています.
研究 の 目的:
- PHO5遺伝子転写の調節におけるPHO4リン酸化の役割を調査する.
- PHO80-PHO85複合体がPHO4の局所化と機能にどのように影響するかを決定する.
- PHO4リン酸化の特定の部位と,その遺伝子の抑制への影響を特定する.
主な方法:
- 酵母遺伝学と分子生物学技術が採用されました.
- 異なるリン酸条件下でのPHO4タンパク質の局所化の分析.
- 生化学的方法を使用してPHO4のリン酸化部位を特定する.
主要な成果:
- PHO4は,フォスファート豊富な環境で,PHO80-PHO85複合体によってリン酸化される.
- リン酸化により,PHO4が細胞質に蓄積し,PHO5の転写を抑制する.
- PHO4は,リン酸飢餓中に核に局所化し,PHO5転写を活性化します.
- PHO4の特定のリン酸化部位が特定され,抑制に不可欠であることが確認されました.
結論:
- PHO80-PHO85によるPHO4のリン酸化は,PHO5の転写を抑制する重要なメカニズムです.
- PHO80-PHO85複合体は,PHO4の核インポートを制御することによって,PHO5発現を調節する.
- この研究は,酵母におけるリン酸ホメオスタシスの重要な規制経路を解明しています.
関連する概念動画
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
00:50Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
00:50Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...